• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 07-May-2021 EOD, Market Closed
SENSEX
49,206.47
256.71 (0.52%)
NIFTY
14,823.15
98.35 (0.67%)
    No Companies Visited

Back to news list
  • Bajaj Healthcare soars on launching Favipiravir tablets for COVID-19 treatment

    Bajaj Healthcare jumped 11.56% to Rs 586.80 after the company announced the launch antiviral Favipiravir tablets, under the brand name Favijaj, for the treatment of mild to moderate COVID-19.



    In a regulatory filing made during market hours today, the company said that the tablets comprising Favipiravir in different dosage forms is used for the treatment of mild to moderate COVID-19 disease. Favipiravir is an antiviral drug, which has shown potent in vitro activity against severe acute respiratory syndrome of coronavirus.

    The company has successfully developed the active pharmaceutical ingredient (API) and the formulation for Favipiravir through its own in-house R&D team. Most patients ailing from mild to moderate symptoms can benefit from the use of Favijaj. The drug will be available as a prescription-based medication, with recommended doses.

    The drug controller of India's has granted permissions to supply the Favijaj (Favipiravir) in the domestic as well as in overseas market.

    Anil Jain, Joint Managing director, Bajaj Healthcare, said: "We are pleased to add Favipiravir to our growing product portfolios. The second waves is more aggressive and bigger in number than the first. We hope the availability of an effective treatment such as Favijaj will considerably ease the pressure, and offer patients much needed and timely therapy option."

    Bajaj Healthcare is a leading manufacturer of APIs, intermediates and formulations.

    The company's net profit surged to Rs 326.1% to Rs 26.42 crore on a 79.6% to Rs 178.33 crore in Q3 FY21 over Q3 FY20.

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 07-May-2021
  •  ( 15:45) European markets trade higher  
  •  ( 15:43) Metal stocks shine  
  •  ( 15:43) Sensex rises 256 pts on positive global signals  
  •  ( 14:32) Sensex, Nifty trade range bound with gains  
  •  ( 13:46) The Nifty index continues to hover below 14,800; Asian markets trade mixed  
  •  ( 13:45) Indices trade range bound; positive market breadth  
  •  ( 12:59) LIC of India hikes 2.03% stake in IRB Infrastructure Developers  
  •  ( 12:42) RailTel Corp. bags order win worth Rs 11.99 cr from Cotton Corp.  
  •  ( 12:32) Metal stocks shine  
  •  ( 12:32) Market breadth positive  
  •  ( 12:31) Indices pare gains  
  •  ( 12:31) Praj Industries consol. Q4 FY21 PAT up 109.2% Y-o-Y to Rs 52.01 cr  
  •  ( 11:57) Raymond consol. Q4 FY21 PAT stands at Rs 58.36 cr  
  •  ( 11:27) Procter & Gamble Health Q3 FY21 PAT down 66.1% Y-o-Y to Rs 15.77 cr  
  •  ( 11:27) Procter & Gamble Health Q4 FY21 PAT down 66.1% Y-o-Y to Rs 15.77 cr  
  •  ( 11:02) Blue Star records PAT of Rs 67.97 crore in Q4 FY21 vs Rs 8.90 crore in Q4 FY20  
  •  ( 10:57) Adani Transmission consol. Q4 FY21 PAT up 335.1% Y-o-Y to Rs 256.55 cr  
  •  ( 10:31) Market breadth positive  
  •  ( 10:30) Indices trade sideways with gains  
  •  ( 10:02) Adani Power consol. Q4 FY21 PAT stands at Rs 13.13 cr  
  •  ( 09:37) Cupid receives order from Uttar Pradesh Medical Supplies Corporation for Rs 10.5 cr  
  •  ( 09:32) Hero MotoCorp Q4 PAT up over 39% YoY to Rs 865 crore  
  •  ( 09:29) Sensex moves above 49,000; breadth strong   
  •  ( 09:25) UK-based Infinity Circle selects Zensar Technologies to manage wealth biz.  
  •  ( 08:09) Asian stocks advance as investors look ahead to U.S. jobs report  
Show News
07 May 2021 00:00
2551.50
(0.10 %)
716.75
(0.13 %)
3867.10
(-1.94 %)
5491.05
(-0.69 %)
11315.60
(2.59 %)
568.50
(1.82 %)
5173.55
(0.15 %)
2496.25
(2.70 %)
916.25
(0.06 %)
1414.60
(0.94 %)
2413.00
(1.00 %)
606.75
(-0.31 %)
925.60
(0.07 %)
1352.40
(-0.64 %)
205.35
(1.28 %)
1779.95
(-0.39 %)
1342.90
(0.23 %)
767.15
(2.68 %)
6702.90
(0.56 %)
16753.55
(0.16 %)
105.05
(2.04 %)
111.50
(1.27 %)
214.60
(-0.37 %)
1931.30
(0.07 %)
358.20
(0.76 %)
679.50
(0.04 %)
3132.00
(0.67 %)
980.80
(0.31 %)
1448.70
(0.36 %)
6484.80
(1.23 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.